STOCK TITAN

Cencora, Inc. - COR STOCK NEWS

Welcome to our dedicated page for Cencora news (Ticker: COR), a resource for investors and traders seeking the latest updates and insights on Cencora stock.

Cencora, Inc. (NYSE: COR) is a premier global pharmaceutical solutions provider committed to enhancing healthcare delivery and improving lives worldwide.

As one of the top three pharmaceutical wholesalers in the United States, Cencora specializes in sourcing and distributing branded, generic, and specialty pharmaceutical products to a diverse range of clients, including retail chains, independent pharmacies, mail-order services, hospital networks, and healthcare providers. In collaboration with McKesson and Cardinal Health, Cencora dominates over 90% of the U.S. pharmaceutical wholesale market.

Beyond its robust domestic operations, Cencora has significantly expanded its international footprint. Notably, the acquisition of Alliance Healthcare in 2021 bolstered its presence in Europe, making it one of the leading drug wholesalers in the region.

Additionally, Cencora offers comprehensive commercialization services for pharmaceutical and medical device manufacturers. Its global specialty drug logistics division, World Courier, is renowned for its precision and reliability. The company also extends its expertise to animal health product distribution through MWI Animal Health.

Cencora's strategic partnerships and innovative solutions drive operational efficiency, cost control, and growth opportunities across the healthcare supply chain.

  • Its pharmacy solutions enhance operational efficiency, cost control, growth opportunities, and patient safety.
  • Provider solutions focus on improving operational efficiency, financial performance, and quality of care.
  • Manufacturer solutions are designed to maximize success at every stage of the product lifecycle.


Recent achievements include a distribution agreement with Sapphiros, enhancing access to COVID-19 Antigen Rapid Tests and future diagnostic technologies in the U.S. market. This partnership is poised to bring innovative diagnostic solutions directly to patients, exemplifying Cencora's commitment to improving accessibility and convenience in healthcare.

Cencora’s mission is driven by a strong sense of purpose: 'We are united in our responsibility to create healthier futures.' Ranked #11 on the Fortune 500 and #24 on the Global Fortune 500, with annual revenues exceeding $250 billion, Cencora’s over 46,000 team members worldwide are dedicated to delivering positive health outcomes through their expertise and collaborative efforts.

Rhea-AI Summary

CoreSite Realty Corporation (NYSE:COR) reported strong Q3 2021 financial results, showcasing a 6.4% year-over-year revenue growth to $163.9 million. Net income remained stable at $0.50 per diluted share. Notably, adjusted EBITDA rose 5.2% to $85.7 million, while Funds From Operations (FFO) increased 4.5% to $1.39 per share. The company renewed 296 leases, reflecting an increase in cash and GAAP rent. Updated guidance for capital expenditures is now $140 million to $150 million, a reduction from the earlier range. Overall, CoreSite's strategic leasing and development activities remain robust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.96%
Tags
-
Rhea-AI Summary

CoreSite Realty Corporation (NYSE:COR) will host its third quarter 2021 earnings conference call on October 28, 2021, at 12:00 p.m. ET. Financial results will be released before market open on the same day. Investors can join the call by dialing 1-877-407-3982 (domestic) or 1-201-493-6780 (international). A replay will be available until November 4, 2021. The call will also be broadcast as a webcast on the company's website, providing insights into its performance and strategies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.24%
Tags
-
Rhea-AI Summary

CoreSite Realty Corporation (NYSE:COR) announced the successful completion of its annual compliance examinations for colocation services across 22 data centers. This achievement reinforces its commitment to operational excellence and customer experience, facilitating industry standard compliance. The examinations included SOC 1 Type 2, SOC 2 Type 2, ISO 27001, NIST 800-53, PCI DSS, and HIPAA certifications. Conducted by Schellman & Company, these validations provide assurance of CoreSite’s robust security and operational controls, essential for customers in various sectors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.21%
Tags
none
Rhea-AI Summary

CoreSite Realty Corporation (NYSE:COR) has announced a cash dividend of $1.27 per share on common stock for Q3 2021, maintaining the previous quarter's amount. The dividend is scheduled for payment on October 15, 2021, to shareholders of record as of September 30, 2021. CoreSite is recognized for its secure, reliable data center campuses with high uptime and provides cloud access and interconnection solutions across major U.S. markets, serving over 1,375 enterprises, network operators, and cloud providers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.13%
Tags
dividends
-
Rhea-AI Summary

CoreSite Realty Corporation (NYSE:COR) will present at the 7th Annual Cowen Communications Infrastructure Summit on August 10th. Chief Revenue Officer Steve Smith is scheduled to speak at 9:30 AM Mountain Time in Boulder, CO. Investors can access the live presentation through the Investor Relations section on CoreSite's website, with a replay available afterward. CoreSite is known for its secure, high-uptime data centers and scalable solutions, connecting a diverse customer ecosystem across eight North American markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.49%
Tags
conferences
-
Rhea-AI Summary

CoreSite Realty Corporation (NYSE:COR) reported strong Q2 2021 results, with operating revenues of $162.1 million, a 7.7% year-over-year increase. Net income was $28.5 million, translating to $0.59 per diluted share, up by $0.07 year-over-year. Adjusted EBITDA grew by 7.1% to $87.4 million. The company commenced 133 new leases, generating $8.4 million in annualized GAAP rent. Key developments included a new chiller plant project aimed at enhancing energy efficiency. CoreSite updated its full-year revenue guidance to $645-$653 million, reflecting positive growth projections.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.13%
Tags
Rhea-AI Summary

CoreSite Realty Corporation (NYSE:COR) has announced support for Google Cloud's Partner Interconnect, enhancing its Silicon Valley campus with low-latency fiber connectivity. This service enables direct internet peering and Dedicated Interconnect options, offering secure 10G and 100G connectivity at competitive costs. The expansion caters to local enterprises requiring high bandwidth and low latency for data transfer, reinforcing CoreSite's growing capabilities across multiple U.S. markets. This strategic development enhances customer options for optimal cloud access and interoperability amidst increasing performance demands.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.45%
Tags
none
-
Rhea-AI Summary

CoreSite Realty Corporation (NYSE:COR) has strengthened its partnership with Google Cloud by introducing enhanced connectivity options, including Google Cloud's Partner Interconnect on its Chicago campus. This initiative aims to support global enterprises in sectors like financial services and healthcare, enabling them to address high-bandwidth, low-latency requirements. The integration simplifies hybrid IT strategies while optimizing performance and reducing costs. CoreSite's offerings now extend across multiple markets, enhancing multi-cloud and multi-region connections.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.16%
Tags
none
-
Rhea-AI Summary

CoreSite Realty Corporation (NYSE:COR) has announced that it will host its second quarter 2021 earnings conference call on July 29, 2021, at 12:00 p.m. Eastern Time. Financial results will be issued prior to market open that same day. Investors can access the call by dialing 1-877-407-3982 (domestic) or 1-201-493-6780 (international). A replay will be available until August 5, 2021. CoreSite offers secure, high-uptime data center solutions with services in eight major North American markets, serving over 1,375 leading enterprises and providers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.7%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.15%
Tags
none

FAQ

What is the current stock price of Cencora (COR)?

The current stock price of Cencora (COR) is $227.69 as of December 20, 2024.

What is the market cap of Cencora (COR)?

The market cap of Cencora (COR) is approximately 43.8B.

What does Cencora, Inc. do?

Cencora, Inc. is a leading global pharmaceutical solutions provider, specializing in the sourcing and distribution of branded, generic, and specialty pharmaceuticals.

Who are Cencora's main clients?

Cencora serves retail chains, independent pharmacies, mail-order services, hospital networks, and healthcare providers.

What are some recent achievements of Cencora?

Cencora recently entered into a distribution agreement with Sapphiros to enhance access to COVID-19 Antigen Rapid Tests and future diagnostic technologies in the U.S.

How significant is Cencora in the U.S. pharmaceutical wholesale market?

Cencora, along with McKesson and Cardinal Health, constitutes over 90% of the U.S. pharmaceutical wholesale industry.

What international presence does Cencora have?

Cencora expanded its international presence by acquiring Alliance Healthcare in 2021, becoming a leading drug wholesaler in Europe.

What other services does Cencora provide?

Cencora offers commercialization services for pharmaceutical and medical device manufacturers, global specialty drug logistics, and animal health product distribution.

What is Cencora’s mission?

Cencora's mission is 'We are united in our responsibility to create healthier futures.'

How is Cencora ranked on the Fortune 500?

Cencora is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500.

What is the scale of Cencora's operations?

Cencora has over 46,000 employees worldwide and generates more than $250 billion in annual revenue.

What are some key solutions provided by Cencora?

Cencora provides pharmacy solutions for operational efficiency and patient safety, provider solutions for quality care, and manufacturer solutions for product lifecycle success.

Cencora, Inc.

NYSE:COR

COR Rankings

COR Stock Data

43.82B
172.54M
10.72%
93.69%
5.17%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States of America
CONSHOHOCKEN